when was semaglutide fda approved Kids for weight loss drugs! The FDA approved a pill
Description
Patients should be counseled about potential out-of-pocket costs and available manufacturer assistance programs before starting therapy
This can lead to fewer blood sugar spikes and a reduced need for additional medications
This study contributes postmarket evidence on the neuropsychiatric safety profile of GLP-1RA

TRIUMPH-4, the first completed Phase 3 trial, showed 28.7% average body weight loss at 68 weeks on retatrutide 12mg versus 2.1% on placebo, as reported by Eli Lilly in December 2025 (peer-reviewed publication pending)

Retatrutide has not yet received marketing authorisation from the MHRA or the EMA, and therefore no official UK or European prescribing guidelines currently exist for this agent

Mounjaro is exclusively available from Eli Lilly and Company
